259 related articles for article (PubMed ID: 9143853)
1. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
Jennings PE
Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Comparative tolerability profiles of oral antidiabetic agents.
Krentz AJ; Ferner RE; Bailey CJ
Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimisation of oral hypoglycaemic therapy.
Marchetti P; Giannarelli R; di Carlo A; Navalesi R
Clin Pharmacokinet; 1991 Oct; 21(4):308-17. PubMed ID: 1760902
[TBL] [Abstract][Full Text] [Related]
5. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
6. Antihyperglycaemic agents. Drug interactions of clinical importance.
Scheen AJ; Lefèbvre PJ
Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982
[TBL] [Abstract][Full Text] [Related]
7. Oral antidiabetic drugs: an overview.
Melander A
Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
[TBL] [Abstract][Full Text] [Related]
8. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Wolffenbuttel BH; van Haeften TW
Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.
Marchetti P; Navalesi R
Clin Pharmacokinet; 1989 Feb; 16(2):100-28. PubMed ID: 2656043
[TBL] [Abstract][Full Text] [Related]
10. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes.
Scheen AJ; Castillo MJ; Lefèbvre PJ
Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.
Tan GH; Nelson RL
Mayo Clin Proc; 1996 Aug; 71(8):763-8. PubMed ID: 8691897
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.
Harrower AD
Clin Pharmacokinet; 1996 Aug; 31(2):111-9. PubMed ID: 8853933
[TBL] [Abstract][Full Text] [Related]
14. Management of antidiabetic medications in overdose.
Spiller HA
Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953
[TBL] [Abstract][Full Text] [Related]
15. Problems and pitfalls of sulphonylurea therapy in older patients.
Robertson DA; Home PD
Drugs Aging; 1993; 3(6):510-24. PubMed ID: 8312676
[TBL] [Abstract][Full Text] [Related]
16. The role of sulphonylureas in the management of type 2 diabetes mellitus.
Rendell M
Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
[TBL] [Abstract][Full Text] [Related]
17. Oral combination therapy for type 2 diabetes.
Charpentier G
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
[TBL] [Abstract][Full Text] [Related]
18. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
20. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Scheen AJ
Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]